In the third episode of a four-part series on autoimmune encephalitis, Dr. Justin Abbatemarco talks with Drs. Eoin Flanagan and Grace Gombolay about a practical approach to testing for auto antibodies and autoimmune encephalitis. Visit NPUb.org/Podcast for additional podcasts and associated article links.

In the third episode of a four-part series on autoimmune encephalitis, Dr. Justin Abbatemarco talks with Drs. Eoin Flanagan and Grace Gombolay about a practical approach to testing for auto antibodies and autoimmune encephalitis. Visit <a href="http://NPUb.org/Podcast" rel="nofollow" target="_blank">NPUb.org/Podcast</a> for additional podcasts and associated article links.

Autoimmune Encephalitis Series: Expanding the Differential

In the second episode of a four-part series on autoimmune encephalitis, Dr. Justin Abbatemarco talks with Drs. Sarosh Irani and John Soltys about a practical approach to testing for auto antibodies and autoimmune encephalitis. Visit NPUb.org/Podcast for additional podcasts and associated article links.

In the second episode of a four-part series on autoimmune encephalitis, Dr. Justin Abbatemarco talks with Drs. Sarosh Irani and John Soltys about a practical approach to testing for auto antibodies and autoimmune encephalitis. Visit <a href="NPUb.org/Podcast" rel="noopener nofollow" target="_blank">NPUb.org/Podcast</a> for additional podcasts and associated article links.

Autoimmune Encephalitis Series: A Rationale Approach to Diagnostics and Interpretation

In the first episode of a four-part series on autoimmune encephalitis, Dr. Justin Abbatemarco talks with Dr. Josep Dalmau about relevant updates on autoimmune encephalitis, ongoing/upcoming clinical trials, and so much more. Visit NPUb.org/Podcast for additional podcasts and associated article links.

In the first episode of a four-part series on autoimmune encephalitis, Dr. Justin Abbatemarco talks with Dr. Josep Dalmau about relevant updates on autoimmune encephalitis, ongoing/upcoming clinical trials, and so much more. Visit <a href="http://NPUb.org/Podcast" rel="nofollow" target="_blank">NPUb.org/Podcast</a> for additional podcasts and associated article links.

Autoimmune Encephalitis Series: Advancing the Science

In this first episode of our three-part series, Prof. Jon Stone talks with Drs. Selma Aybek, David Perez, and Sarah Lidstone about FND diagnosis and exploring new phenotypes. Associated Links:  FND Society at fndsociety.org FND guide for patients at neurosymptoms.org FND Hope at fndhope.org  Visit NPUb.org/Podcast for associated article links. This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.

In this first episode of our three-part series, Prof. Jon Stone talks with Drs. Selma Aybek, David Perez, and Sarah Lidstone about FND diagnosis and exploring new phenotypes. Associated Links: <ul> <li>FND Society at <a href="http://fndsociety.org/" rel="nofollow" target="_blank">fndsociety.org</a></li> <li>FND guide for patients at <a href="http://neurosymptoms.org/" rel="nofollow" target="_blank">neurosymptoms.org</a></li> <li>FND Hope at <a href="http://fndhope.org/" rel="nofollow" target="_blank">fndhope.org</a></li> </ul> Visit <a href="http://npub.org/Podcast" rel="nofollow" target="_blank">NPUb.org/Podcast</a> for associated article links. This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.

An Updated Round Table Discussion on FND:  Diagnosis of FND and New Phenotypes

The August 2023 replay of past episodes showcases four interviews on functional neurologic disorders with Prof. Jon Stone. The episode begins with an interview by Prof. Jon Stone and Dr. Tamara Pringsheim with Wall Street Journal columnist Julie Jargon about the increased incidence of teen girls presenting with physical tics. The Recall episode continues with an interview with Drs. Tamara Pringsheim and Davide Martino about the latest updates on those functional tics and new diagnostic criteria. The third interview is with Dr. Tjerk Lagrand about how the diagnosis of functional seizures affects health care costs. The August Recall concludes with Dr. Mahinda Yogarajah about the importance of diagnosing and not misdiagnosing functional neurologic disorders.   Related Podcast Links:  Tik Tok Tics - https://directory.libsyn.com/episode/index/id/21928034 Functional Tic Update - https://directory.libsyn.com/episode/index/id/26601993 Health Care Utilization in FND - https://directory.libsyn.com/episode/index/id/25624821 Economic Cost of Functional Neurologic Disorders - https://directory.libsyn.com/episode/index/id/27225606  Related Article Links:  How Teens Recovered from the 'Tik Tok Tics' -  https://www.nytimes.com/2023/02/13/health/tiktok-tics-gender-tourettes.html Economic Cost of Functional Neurologic Disorders: A Systematic Review:  https://n.neurology.org/content/early/2023/06/20/WNL.0000000000207388  

The August 2023 replay of past episodes showcases four interviews on functional neurologic disorders with Prof. Jon Stone. The episode begins with an interview by Prof. Jon Stone and Dr. Tamara Pringsheim with Wall Street Journal columnist Julie Jargon about the <a href="https://directory.libsyn.com/episode/index/id/21928034" rel="noopener nofollow" target="_blank">increased incidence of teen girls presenting with physical tics</a>. The Recall episode continues with an interview with Drs. Tamara Pringsheim and Davide Martino about the latest updates on those functional tics and <a href="https://directory.libsyn.com/episode/index/id/26601993" rel="noopener nofollow" target="_blank">new diagnostic criteria</a>. The third interview is with Dr. Tjerk Lagrand about how the diagnosis of <a href="https://directory.libsyn.com/episode/index/id/25624821" rel="noopener nofollow" target="_blank">functional seizures affects health care costs</a>. The August Recall concludes with Dr. Mahinda Yogarajah about the importance of diagnosing and <a href="https://directory.libsyn.com/episode/index/id/27225606" rel="noopener nofollow" target="_blank">not misdiagnosing functional neurologic disorders</a>. Related Podcast Links: <ol> <li>Tik Tok Tics - <a href="https://directory.libsyn.com/episode/index/id/21928034" rel="nofollow" target="_blank">https://directory.libsyn.com/episode/index/id/21928034</a></li> <li>Functional Tic Update - <a href="https://directory.libsyn.com/episode/index/id/26601993" rel="nofollow" target="_blank">https://directory.libsyn.com/episode/index/id/26601993</a></li> <li>Health Care Utilization in FND - <a href="https://directory.libsyn.com/episode/index/id/25624821" rel="nofollow" target="_blank">https://directory.libsyn.com/episode/index/id/25624821</a></li> <li>Economic Cost of Functional Neurologic Disorders - <a href="https://directory.libsyn.com/episode/index/id/27225606" rel="nofollow" target="_blank">https://directory.libsyn.com/episode/index/id/27225606</a></li> </ol> Related Article Links: <ol> <li>How Teens Recovered from the 'Tik Tok Tics' - <a href="https://www.nytimes.com/2023/02/13/health/tiktok-tics-gender-tourettes.html" rel="nofollow" target="_blank"> https://www.nytimes.com/2023/02/13/health/tiktok-tics-gender-tourettes.html</a></li> <li>Economic Cost of Functional Neurologic Disorders: A Systematic Review: <a href="https://n.neurology.org/content/early/2023/06/20/WNL.0000000000207388" rel="nofollow" target="_blank"> https://n.neurology.org/content/early/2023/06/20/WNL.0000000000207388</a> </li> </ol>

August 2023 Neurology Recall: Functional Neurologic Disorders

Dr. Stacey Clardy talks with Dr. Natalia Rost about her experience speaking before the House of Representatives on the approval of lecanemab for the treatment of early Alzheimer disease. Visit NPUb.org/Podcast for associated article links. This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.

Dr. Stacey Clardy talks with Dr. Natalia Rost about her experience speaking before the House of Representatives on the approval of lecanemab for the treatment of early Alzheimer disease. Visit <a href="http://NPUb.org/Podcast" rel="nofollow" target="_blank">NPUb.org/Podcast</a> for associated article links. This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.

AAN President Elect Testified Before House Subcommittee on New Alzheimer Treatment

Dr. Justin Abbatemarco talks with Dr. Amel Karaa about the use of elamipretide in participants with genetically confirmed primary mitochondrial myopathies. Read the related article in Neurology.  Visit NPUb.org/Podcast for associated article links.

Dr. Justin Abbatemarco talks with Dr. Amel Karaa about the use of elamipretide in participants with genetically confirmed primary mitochondrial myopathies. Read the related article in <a href="https://n.neurology.org/content/101/3/e238" rel="noopener nofollow" target="_blank">Neurology</a>.  Visit <a href="NPUb.org/Podcast" rel="noopener nofollow" target="_blank">NPUb.org/Podcast</a> for associated article links.

Elamipretide for Mytochondrial Myopathy

Dr. Gordon Smith talks with Dr. Hoda Abdel-Hamid about the recent FDA approval for the first ever gene therapy for Duchenne muscular dystrophy. Visit NPUb.org/Podcast for associated article links.

Dr. Gordon Smith talks with Dr. Hoda Abdel-Hamid about the recent FDA approval for the first ever gene therapy for Duchenne muscular dystrophy. Visit <a href="http://NPUb.org/Podcast" rel="nofollow" target="_blank">NPUb.org/Podcast</a> for associated article links.

Sarepta Announces FDA Approval of ELEVIDYS

Dr. Kathryn Nevel talks with Dr. Ingo Mellinghoff about how vorasidenib improved progression-free survival in patients with Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas. Read the related article in The New England Journal of Medicine. Visit NPUb.org/Podcast for associated article links.

Dr. Kathryn Nevel talks with Dr. Ingo Mellinghoff about how vorasidenib improved progression-free survival in patients with Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas. Read the related article in <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2304194" rel="noopener nofollow" target="_blank">The New England Journal of Medicine.</a> Visit <a href="NPUb.org/Podcast" rel="noopener nofollow" target="_blank">NPUb.org/Podcast</a> for associated article links.

New Treatment for IDH mt Gliomas

Dr. Jason Crowell talks with Prof. Jacob Elberg to provide neurologists with an insight into what goes on behind the scenes for patient-assistance programs.  Read the related article in The New England Journal of Medicine.  Visit NPUb.org/Podcast for associated article links.

Dr. Jason Crowell talks with Prof. Jacob Elberg to provide neurologists with an insight into what goes on behind the scenes for patient-assistance programs.  Read the related article in <a href="https://www.nejm.org/doi/full/10.1056/NEJMp2303535" rel="noopener nofollow" target="_blank">The New England Journal of Medicine</a>.  Visit <a href="http://NPUb.org/Podcast" rel="nofollow" target="_blank">NPUb.org/Podcast</a> for associated article links.

Patient-Assistance Programs, Kickbacks, and the Courts

The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.

Content is definitely a 5 but the audio quality could be better.

Informative and relevant!

Highest praise!!!  A MUST for Neurology residents!

Best brain pod!

Neurology® Podcast

This month's Neurology Recall features Dr. Jason Crowell discussing prion diseases with both Dr. Sonia Vallabh and Nobel Prize Winner Dr. Stanley Prusiner.

This month's Neurology Recall features Dr. Jason Crowell discussing prion diseases with both Dr. Sonia Vallabh and Nobel Prize Winner Dr. Stanley Prusiner.

Prion Diseases (Neurology Recall March 2021)

In this month's Delayed Recall episode, we are featuring four interviews by Dr. Kait Nevel on the topic of neuro-oncology. In the first interview, Dr. Nevel speaks with Dr. Jennie Taylor about neuro-oncology and seizures. In the second, she discusses intracranial pressure with Dr. Mariza Daras. These interviews originally appeared in the March 7 and March 14 episodes, respectively. Next, Dr. Nevel and Dr. Lisa DeAngelis talk about metastatic diseases in neurology, in a segment that appeared in the March 21 episode. Last, Dr. Nevel discusses gliomas with Dr. David Schiff in an interview from March 28.

Delayed Recall -  Neuro-oncology Lessons of the Week (July 2017)

The first interview in this month’s Delayed Recall episode is from March 17, 2015; in this interview, Dr. Howard Goodkin and Dr. Robert Stern discuss the effect that age of first exposure to football has on later-life cognitive impairment in former NFL players. The second interview, from August 29, 2017, is a discussion between Dr. Jason Crowell and Dr. Jesse Mez about a July 2017 JAMA paper on occurrence of CTE in American football players. In the third interview, Dr. Christopher Giza speaks with Dr. John Hart about Dr. Hart’s paper regarding depressive symptoms and white matter dysfunction in retired NFL players with concussion history. This interview originally appeared in the July 1, 2013 episode. The fourth and final interview is a discussion between Dr. Ted Burns and former NFL player Ben Utecht, regarding Mr. Utecht’s Sept 23, 2014 editorial, “Concussed.”

Delayed Recall - Concussion and Chronic Traumatic Encephalopathy (September 2017)

Interviews on evaluation of the anoxic brain injury patient.

Delayed Recall - Anoxic brain injury (October 2016)

1) AAN paper on efficacy and safety of the therapeutic use of medical marijuana (Cannabis) in selected neurologic disorders and 2) Topic of the month: Therapeutics in epilepsy. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Joanna Suski interviews Dr. Barbara Koppel about the AAN paper on efficacy and safety of the therapeutic use of medical marijuana (Cannabis) in selected neurologic disorders. Dr. Adam Numis is reading our e-Pearl of the week about myoclonic astatic epilepsy. In the next part of the podcast Dr. Lara Marcuse interviews Dr. Greg Bergey about epilepsy therapeutics: Beyond medications for the refractory patient. The participants had nothing to disclose except Drs. Koppel, Numis and Bergey.Dr. Koppel serves as an editorial board member of Clinical Neurology.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Bergey was an expert witness in medicolegal activity over the past two years and receives research support from the NIH.

April 29 2014 Issue

Tele-neurology and tele-stroke - from September 2015 LOTWs

Delayed Recall - March 2016

We are producing and releasing 4 special podcast interviews this month dedicated to responsible opioid prescribing. We are doing this largely as a response to the ongoing opioid epidemic in the U.S. and around the world. In Special Podcasts 3 and 4, Dr. Andy Southerland interviews Dr. Gary Franklin from the University of Washington. Many state boards in the U.S. are now requiring a few hours of CME for responsible opioid prescribing practices, and these podcasts may be eligible for a total 2 hours of Category 1 CME, however please check with your individual U.S. state Board of Medicine mandates. Regardless of CME, we felt these topics deserved covering and we hope you check out all four episodes and find them helpful and informative.

Responsible Opioid Prescribing—Special Podcast #3

1) Skin nerve a-synuclein deposits being a biomarker for idiopathic Parkinson disease and 2) Topic of the month: Therapeutics in epilepsy. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Ratliff interviews Dr. Vincenzo Donadio about his paper on skin nerve ?-synuclein deposits being a biomarker for idiopathic Parkinson disease. Dr. Adam Numis is reading our e-Pearl of the week about cognitive impairment in pediatric multiple sclerosis. In the next part of the podcast Dr. Lara Marcuse interviews Dr. Nathan Fountain about epilepsy therapeutics: Lacosamide. The participants had nothing to disclose except Drs. Fountain and Numis.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Fountain serves as Vice-President of the National Association of Epilepsy Centers; performs EEG lab work and EEG interpretation in his clinical practice (10% effort); receives research support from UCB, SK Life Sciences, Sunovion, Medtronic, NeuroPace; and the NIH.

April 15 2014 Issue

1) Natural history of cavernous malformation: Systematic review and meta-analysis of 25 studies2) e-Pearl topic: Neurologic manifestations of hereditary hemorrhagic telangiectasia3) Topic of the month: Neurology Today story about new Center for Disease Control guidelines on prescribing opioids (Part 1)This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Matthew Flaherty interviews Dr. Loch Macdonald about his paper on review and meta-analysis of 25 studies about the natural history of cavernous malformation. Dr. Adam Numis is reading our e-Pearl of the week about neurologic manifestations of hereditary hemorrhagic telangiectasia. Dr. Ted Burns interviews Dr. Gary Franklin about a Neurology Today story on the topic of the new Center for Disease Control guidelines on prescribing opioids (Part 1).DISCLOSURES: Dr. Flaherty serves on the scientific advisory board for DSMB member, I-DEF Trial (NINDS sponsored ICH treatment trial); has a patent pending, non-invasive CNS monitor; owns company stock as co-founder of SENSE Diagnostics, LLC (our product is currently investigational and not on the market); serves on the speakers' bureau of CSL Behring and Janssen; receives research support from American Heart Association, Pfizer Inc, Bristol-Myers Squibb, NIH and as Principal Investigator of a phase II, NINDS funded trial testing recombinant activated factor VII for treatment of intracerebral hemorrhage where study drug is supplied by Novo Nordisk.Dr. Macdonald serves as an editorial board member of Stroke, Journal of Neurosurgery, Neurosurgery, Journal of cerebral blood flow and metabolism, Neurocritical care, World Neurosurgery, Surgical Neurology International, Translational stroke research and Cerebrovascular diseases; treats unruptured aneurysm patients (1% effort); holds stock options in Edge Therapeutics, Inc; has a patent for treatment of delayed cerebral ischemia and subdural hemorrhage, intracranial drug delivery systems; receives research support from Canadian Institutes of Health Research, Brain Aneurysm Foundation, Heart and Stroke Foundation of Canada and Physicians Services Incorporated Foundation.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section.Dr. Ted Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc.Dr. Franklin serves as an editorial board member of Neuroepidemiology; serves on the Levels of Evidence Team for Neurology®; is a consultant for the California State Compensation Insurance Fund; receives research support from the Centers for Disease Control and Prevention.

May 24 2016 Issue

Patient Perspectives, Part II (January 2018)This month’s Delayed Recall episode is the second part of our feature including interviews that focus on the patient perspective. The first part of this feature aired as the Delayed Recall episode for December 2017. We feature four interviews in this second installment; the first is Dr. Alberto Espay’s interview with Dr. Ted Burns in the Sept. 3, 2013 episode, in which they discuss Dr. Burns’ cancer diagnosis and his subsequent experience as a patient. In the second interview, with Dr. Lara Marcuse, Dr. Marcuse responds to Dr. Espay’s Sept. 2013 interview with Dr. Burns, and remarks briefly on her own time as a patient. This interview was part of the October 29, 2013 episode. The third interview features Dr. Espay and Dr. Burns once more; they discuss Dr. Burns’ cancer recurrence, as well as Dr. Burns’ view about the kind of care that he believes is important for healthcare providers to focus on. This interview first appeared in the August 1, 2017 episode. Last, we feature an interview from the June 3, 2008 episode, between Dr. Ted Burns and Dr. Bob Joynt, in which Dr. Joynt offers his advice regarding patient treatment.

Delayed Recall - Patient Perspectives, Part II (January 2018)

This month’s Delayed Recall highlights episodes on stroke risk, prevention and treatment. Dr. Jim Siegler and Dr. Christian Gerloff begin the show discussing the results of the WAKE-UP stroke trial. This episode first aired on October 2, 2018. The next segment, from September 11, 2018 focuses on acute ischemic stroke, where Dr. Dan Ackerman talks with Dr. Andrei Alexandrov about his paper on dual antiplatelet therapy pretreatment. This interview is followed by a segment that first appeared in the August 21, 2018 show on silent infarct and the risk of infarct recurrence in adults with sickle cell anemia with Dr. Justin Sattin and Dr. Lori Jordan. The episode concludes with another interview on acute ischemic stroke from August 14, 2018 investigating a POINT study on Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA with Dr. Will Rondeau interviewing Dr. Clay Johnston.

Stroke risk, prevention and treatment (Delayed Recall - November 2018)

This month’s Delayed Recall episode includes three recent interviews on the topic of cognitive impairment. In the first interview, from the January 16, 2018 episode, Dr. Jeff Burns speaks with Dr. Ronald Petersen about the recent AAN practice guideline paper on mild cognitive impairment. Next, in and interview from the January 2, 2018 podcast, Dr. Ted Burns and Dr. Damian Garde discuss recent Alzheimer disease trials; and in the third and final interview, Dr. Matthew Elliot talks with Dr. Hugh Markus about his paper “Multimodal MRI markers and dementia risk in cerebral small vessel disease.” This interview first aired in the October 31, 2017 episode of the podcast.

Delayed Recall - Cognitive Impairment (March 2018)

Ted Burns

In this replay of a past Delayed Recall, Dr. Ted Burns talks with Dr. Dean Buonomano, author of Brain Bugs, on how the brain makes and forgets memories.

In this replay of a past Delayed Recall, Dr. Ted Burns talks with Dr. Dean Buonomano, author of Brain Bugs, on how the brain makes and forgets memories.

Neurology Recall:  How the Brain makes -- and forgets -- memories, with Dean Buonomano  and Ted Burns

This special Delayed Recall episode is the third installment of our new Practice Current segment. In this episode, Dr. Luca Bartolini speaks with epilepsy experts Dr. Cynthia Harden and Dr. Torbjörn Tomson. They discuss the results of a recent Practice Current (a section of Neurology® Clinical Practice) survey regarding epilepsy treatment and management during pregnancy, and share their thoughts regarding best practices. This is the first appearance of this interview in the podcast.

Practice Current: Managing Epilepsy during Pregnancy (April 2018)

Oliver Sacks

In the first segment, Dr. Stacey Clardy continues her talk with Dr. Lawrence Weschler about his book on Oliver Sacks, And How are You, Dr. Sacks?, in the second of a two-part interview. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Andrew Mammen about his paper on more prominent muscle involvement in dermatomyositis patients with anti-Mi2 autoantibodies. 

In the first segment, Dr. Stacey Clardy continues her talk with Dr. Lawrence Weschler about his book on Oliver Sacks, And How are You, Dr. Sacks?, in the second of a two-part interview. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Andrew Mammen about his paper on more prominent muscle involvement in dermatomyositis patients with anti-Mi2 autoantibodies.

Life of Oliver Sacks; Mi-2 dermatomyositis

Stanley Prusiner

In the first segment, Dr. Jeffrey Ratliff talks with Dr. Ylva Hiorth and about their paper on a 7-year prospective population-based study on orthostatic hypotension in Parkinson disease. In the second part of the podcast, Dr. Jason Crowell talks with Nobel Prize winner Dr. Stanley B. Prusiner in the first part of a two-part interview. Disclosures can be found at Neurology.org. CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

In the first segment, Dr. Jeffrey Ratliff talks with Dr. Ylva Hiorth and about their paper on a 7-year prospective population-based study on orthostatic hypotension in Parkinson disease. In the second part of the podcast, Dr. Jason Crowell talks with Nobel Prize winner Dr. Stanley B. Prusiner in the first part of a two-part interview. Disclosures can be found at <a href="http://Neurology.org" rel="nofollow" target="_blank">Neurology.org</a>. CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

Clinical Management of Orthostatic Hypotension in PD and a discussion with Nobel Laureate Stanley Prusiner about his impact on neurology

This month’s Delayed Recall highlights 6 interviews on encephalopathies from the March and April 2013 Delayed Recall episodes. You’ll hear about encephalopathies caused by endocrine disorders, by electrolyte disorders, by liver and kidney failure, and by other organ failure. The other interviews cover encephalopathies caused by systemic disease, such as encephalopathies caused by drugs or miscellaneous causes, including vitamin deficiencies and autoimmune disorders.

This month’s Delayed Recall highlights 6 interviews on encephalopathies from the March and April 2013 Delayed Recall episodes. You’ll hear about encephalopathies caused by endocrine disorders, by electrolyte disorders, by liver and kidney failure, and by other organ failure. The other interviews cover encephalopathies caused by systemic disease, such as encephalopathies caused by drugs or miscellaneous causes, including vitamin deficiencies and autoimmune disorders.

Encephalopathies (Delayed Recall--March 2020)

Dr. Michelle Mauermann talks with Dr. Mary Reilly about her paper on targeted, next-generation, sequencing panels in the diagnosis of Charcot-Marie-Tooth disease.

Dr. Michelle Mauermann talks with Dr. Mary Reilly about her paper on targeted, next-generation, sequencing panels in the diagnosis of Charcot-Marie-Tooth disease.

Diagnosis of Charcot-Marie-Tooth Disease

1) Zika virus-associated Guillain-Barre Syndrome Variant in Haiti2 e-Pearl topic: Juvenile Huntington Disease3) Topic of the month: Clinical Trials Plenary Session at the AAN meeting about 5-HT6 antagonist as adjunctive therapy to cholinesterase inhibitors in patients with mild-to-moderate Alzheimer diseaseThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Stephen Donahue interviews Dr. Aaron Berkowitz about his paper on Zika virus-associated Guillain-Barre syndrome variant in Haiti. Dr. Ilena George is reading our e-Pearl of the week about juvenile Huntington disease. Dr. Alberto Espay interviews Dr. Alireza Atri about his Clinical Trials Plenary Session at the AAN meeting about 5-HT6 antagonist as adjunctive therapy to cholinesterase inhibitors in patients with mild-to-moderate Alzheimer disease.DISCLOSURES: Dr. Berkowitz receives royalties from the publication of the book: Clinical Pathophysiology Made Ridiculously Simple and the book: The Improvising Mind; received funding for travel from Stevens Institute of Technology; received speaker honorarium from Audio Digest; and received honorarium for recorded CME lecture.Dr. George serves on the editorial team for the Neurology® Resident and Fellow Section.Dr. Espay serves as Associate Editor for the Journal of Clinical Movement Disorders; serves as an editorial board member of Parkinsonism and Related Disorders and The European Neurological Journal; serves on the scientific advisory board for Solvay Pharmaceuticals, Inc. (now Abbvie), Chelsea Therapeutics International, Ltd., Teva Pharmaceutical Industries Ltd., Impax, Merz Pharmaceuticals, Inc., Pfizer Inc, Solstice Neurosciences, Eli Lilly and Company, ACADIA Pharmaceuticals, Inc. and USWorldMeds; is a consultant for Chelsea Therapeutics International, Ltd., Solvay Pharmaceuticals, Inc. (now Abbvie), ACADIA Pharmaceuticals, Inc., Cynapsus and Lundbeck, Inc; receives royalties for publications of books from Lippincott, Williams &amp; Wilkins and Cambridge University Press; serves on the speakers' bureau of UCB, Teva Pharmaceutical Industries Ltd., American Academy of Neurology and Movement Disorders Society; receives research support from the CleveMed/Great Lake Neurotechnilogies, Michael J. Fox Foundation and the NIH.

July 19 2016 Issue

Autoimmune &amp; Paraneoplastic Encephalitis. Lesson of the Week interviews from February 2015.

Delayed Recall - Autoimmune & Paraneoplastic Encephalitis (May 2015)

The best podcast episodes about true crime. For any thrill seeking podcast listeners who just can't get enough of the captivating stories of murderers and criminals. This topic has all the best episodes from many different true crime podcasts.  Add episodes you're interested into your queue below!

Best True Crime Podcasts

The best podcast episodes on romantic relationships. Episodes talk about the 5 love languages, intimacy, and the taboo topics of sexual desires and infidelity. This topic is a deep dive into the science and complexities that face us in our relationships with others. Add episodes you're interested into your queue below!